Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Palonosetron is more effective than ondansetron/dolasetron in preventing chemotherapy-induced nausea and vomiting in patients with breast cancer: combined results of 2 phase 3 trials
    Meeting Abstract

    Hudis, C. A.; Hainsworth, J. D.; Perez, E. A.; Macciocchi, A.
    Breast Cancer Research and Treatment (2003)

    Fulltext@MSK | Save
  • Activated, mutated B-Raf protein kinase requires the Hsp90 chaperone protein for folding and stability and is degraded in response to Hsp90 inhibitors
    Meeting Abstract

    Grbovic, O. M.; Basso, A. D.; Houghton, A.; Solit, D. B.; Rosen, N.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Incremental improvements in QOL related to changes in Hb in breast cancer (BC) patients (pts) receiving adjuvant chemotherapy (ADJCT) and QW epoetin alfa therapy
    Meeting Abstract

    Gralow, J. R.; Hudis, C. A.; Williams, D.
    Blood (2003)

    Fulltext@MSK | Save
  • Gene expression differences between paired primary and metastatic breast carcinomas
    Meeting Abstract

    Giri, D.; Donaton, M.; Olshen, A.; Panageas, K.; Lal, P.; Levcovici, S.; Brogi, E.; Hudis, C.; Van Zee, K.; Tan, L.; more...
    Modern Pathology (2003)

    Fulltext@MSK | Save
  • Gene expression differences between paired primary and metastatic breast carcinomas
    Meeting Abstract

    Giri, D.; Donaton, M.; Olshen, A.; Panageas, K.; Lal, P.; Levcovici, S.; Brogi, E.; Hudis, C.; Van Zee, K.; Tan, L.; more...
    Laboratory Investigation (2003)

    Fulltext@MSK | Save
  • The expression of osteoprotegerin co-localises with columnar cell change in human breast tissue
    Meeting Abstract

    Cross, S. S.; Van Poznak, C.; Hudis, C.; Holen, I.
    Journal of Pathology (2003)

    Fulltext@MSK | Save
  • Benefit of paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer - Reply
    Journal Article

    Henderson, I. C.; Norton, L.; Berry, D. A.
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    Journal Article

    King, M. C.; Marks, J. H.; Mandell, J. B.; The New York Breast Cancer Study Group
    Science (2003)

    Fulltext@MSK | Save
  • Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
    Journal Article

    Henderson, I. C.; Berry, D. A.; Demetri, G. D.; Cirrincione, C. T.; Goldstein, L. J.; Martino, S.; Ingle, J. N.; Cooper, M. R.; Hayes, D. F.; Tkaczuk, K. H.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/Cancer and Leukemia Group B trial 9741
    Journal Article

    Citron, M. L.; Berry, D. A.; Cirrincione, C.; Hudis, C.; Winer, E. P.; Gradishar, W. J.; Davidson, N. E.; Martino, S.; Livingston, R.; Ingle, J. N.; more...
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save